Oncogenic BRAF regulates beta-Trcp expression and NF-kappaB activity in human melanoma cells

J Liu1, K G Suresh Kumar, D Yu

  • 1Department of Animal Biology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104-6046, USA.

Oncogene
|September 27, 2006
PubMed

Insights

Mutant BRAF promotes melanoma cell survival by activating the NF-kappaB pathway. Inhibiting BRAF signaling reduces NF-kappaB activity, leading to melanoma cell death.

Area of Science:

  • Molecular Oncology
  • Cell Signaling

Background:

  • BRAF mutations are common in melanoma, driving cell growth and survival.
  • Melanoma cells display constitutive activation of the anti-apoptotic transcription factor NF-kappaB.
  • NF-kappaB activation is regulated by IkappaB degradation, mediated by IKK and beta-Trcp.

Purpose of the Study:

  • To investigate the role of BRAF signaling in regulating NF-kappaB activity in melanoma.
  • To elucidate the mechanism by which BRAF influences IkappaB degradation and NF-kappaB activation.

Main Methods:

  • Expression analysis of beta-Trcp in melanocytes with oncogenic BRAF.
  • Assay of IKK activity and IkappaBalpha degradation rates.
  • Inhibition of BRAF signaling using a Raf inhibitor (BAY 43-9006) and RNA interference.
  • Assessment of NF-kappaB transcriptional activity and apoptosis induction.

Main Results:

  • Oncogenic BRAF (V600E) expression enhanced beta-Trcp expression, IKK activity, and IkappaBalpha degradation.
  • BRAF inhibition decreased IKK activity, beta-Trcp expression, and IkappaBalpha degradation.
  • BRAF inhibition led to NF-kappaB pathway suppression and increased melanoma cell apoptosis.

Conclusions:

  • Mutational activation of BRAF contributes to constitutive NF-kappaB induction in melanoma.
  • BRAF signaling promotes melanoma cell survival through sustained NF-kappaB activation.
  • Targeting BRAF may represent a therapeutic strategy to sensitize melanoma cells to apoptosis.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...